High Frequency of Poor Locomotor Performance in HIV-infected Patients
Overview
Authors
Affiliations
Objectives: To provide up-to-date assessments of locomotor function in HIV-infected patients and to identify potential determinants of impaired function.
Design: Cross-sectional study in 324 HIV-1-infected adults from the French Agency for AIDS and Hepatitis Research (ANRS) CO3 Aquitaine Cohort using standardized locomotor tests.
Methods: Patients underwent standardized testing assessing balance, walking ability, functional capacity and lower limb muscle performance. Poor test performance was defined by cut-offs based on age-specific data of the general population. Factors associated with poor test performance were studied by logistic regression.
Results: Median age was 48 years, 80% were men and 89% were on antiretroviral treatment. The most frequently altered locomotor test was the five-times sit-to-stand (5STS) test, assessing lower limb muscle performance (poor performance: 53%). In multivariable analysis, time since HIV diagnosis was associated with poor 5STS performance [odds ratio (OR) = 1.08 per year; 95% confidence interval (CI): 1.03, 1.13]. In patients below 30 years, elevated BMI was associated with higher likelihood of good performance (OR = 0.81 per kg/m(2); 95% CI: 0.69, 0.93), whereas in those above 70 years this association was reversed (OR = 1.30 per kg/m(2); 95% CI: 1.10, 1.53; P < 10(-3) for interaction). We found no association with antiretroviral treatment.
Conclusion: One of two adults with controlled HIV infection had poor lower limb muscle performance, which might put this population at risk of falls and fracture. The 5STS test is a simple test that should be recommended to assess muscular performance in HIV care.
Levitt D, Bourgeois B, Rodriguez-Graciani K, Molina P, Simon L Int J Mol Sci. 2024; 25(4).
PMID: 38397125 PMC: 10888832. DOI: 10.3390/ijms25042448.
Factors affecting quality of life in adults with HIV: A local cross-sectional study.
Berner K, Louw Q S Afr J Physiother. 2023; 79(1):1921.
PMID: 38059059 PMC: 10696562. DOI: 10.4102/sajp.v79i1.1921.
Quigley A, Brouillette M, Fellows L, Mayo N BMC Infect Dis. 2021; 21(1):843.
PMID: 34416849 PMC: 8377450. DOI: 10.1186/s12879-021-06540-7.
Bernard C, Font H, Diallo Z, Ahonon R, Tine J, Abouo F PLoS One. 2020; 15(10):e0240906.
PMID: 33091061 PMC: 7580884. DOI: 10.1371/journal.pone.0240906.
Berner K, Cockcroft J, Louw Q Biomed Eng Online. 2020; 19(1):57.
PMID: 32709239 PMC: 7379351. DOI: 10.1186/s12938-020-00802-2.